HITIQ Limited (HIQ.AX)

AUD 0.03

(-14.29%)

EBITDA Summary of HITIQ Limited

  • HITIQ Limited's latest annual EBITDA in 2024 was -2.54 Million AUD , up 41.05% from previous year.
  • HITIQ Limited's latest quarterly EBITDA in 2024 FY was N/A , up 9.14% from previous quarter.
  • HITIQ Limited reported an annual EBITDA of -4.31 Million AUD in 2023, down -4.12% from previous year.
  • HITIQ Limited reported an annual EBITDA of -6.54 Million AUD in 2022, down -36.48% from previous year.
  • HITIQ Limited reported a quarterly EBITDA of -2.9 Million AUD for 2024 Q4, down -99.72% from previous quarter.
  • HITIQ Limited reported a quarterly EBITDA of N/A for 2024 FY, up 9.14% from previous quarter.

Annual EBITDA Chart of HITIQ Limited (2024 - 2019)

Historical Annual EBITDA of HITIQ Limited (2024 - 2019)

Year EBITDA EBITDA Growth
2024 -2.54 Million AUD 41.05%
2023 -4.31 Million AUD -4.12%
2022 -6.54 Million AUD -36.48%
2021 -4.79 Million AUD -34.98%
2020 -2.32 Million AUD 0.0%
2019 - AUD 0.0%

Peer EBITDA Comparison of HITIQ Limited

Name EBITDA EBITDA Difference
Alcidion Group Limited -4.49 Million AUD 43.447%
Artrya Limited -13.95 Million AUD 81.78%
Beamtree Holdings Limited -331 Thousand AUD -668.163%
Cogstate Limited 9.89 Million AUD 125.706%
Careteq Limited -826.61 Thousand AUD -207.594%
Doctor Care Anywhere Group PLC -8.35 Million AUD 69.564%
Emyria Limited -13.03 Million AUD 80.494%
Global Health Limited -1.76 Million AUD -43.995%
Intelicare Holdings Limited -3.02 Million AUD 15.822%
ImExHS Limited -1.25 Million AUD -102.161%
Mach7 Technologies Limited -2.44 Million AUD -4.119%
MedAdvisor Limited 7.04 Million AUD 136.074%
Oakridge International Limited -630.05 Thousand AUD -303.557%
Opyl Limited -3.2 Million AUD 20.772%
PainChek Limited -9.48 Million AUD 73.203%
Pro Medicus Limited 120.76 Million AUD 102.105%
Resonance Health Limited -457 Thousand AUD -456.362%
Singular Health Group Ltd -2.88 Million AUD 11.872%
Total Brain Limited -5.49 Million AUD 53.696%